Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2019

26.01.2019 | Original Article

TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia

verfasst von: C. Paradis, M. Cadieux-Dion, C. Meloche, M. Gravel, J. Paradis, A. Des Roches, G. Leclerc, P. Cossette, P. Begin

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cryofibrinogenemia is a rare cryopathy presenting as acrocyanosis following exposure to cold. Familial presentation has been described but the underlying molecular cause remained undetermined.

Methods

Forty (40) members from a large family with an initial diagnosis of familial cryofibrinogenemia were interviewed and examined to determine affected status and collect DNA. Exome sequencing was performed on three affected individuals from distinct branches of the pedigree.

Results

Seventeen (17) family members reported a history of acrocyanosis with cold exposure. None reported symptoms were suggestive of lupus. Exome sequencing of three subjects identified the heterozygous mutation D18N in the TREX1 gene which was then confirmed by Sanger sequencing in all affected as well as 2 unaffected family members. The mutation is already being associated with familial chilblain lupus erythematosus (CHLE), and a systematic review of literature was undertaken to compare reports of familial CHLE and cryofibrinogenemia. Both entities were found to share highly similar clinical presentations suggesting they are part of a same syndrome in which cryofibrinogenemia and lupus manifestations have variable penetrance.

Conclusions

Familial cryofibrinogenemia without lupus should be added to the spectrum of TREX1-related disease.
Literatur
1.
Zurück zum Zitat Moiseev S, Luqmani R, Novikov P, Shevtsova T. Cryofibrinogenaemia-a neglected disease. Rheumatology (Oxford). 2017;56(9):1445–51. Moiseev S, Luqmani R, Novikov P, Shevtsova T. Cryofibrinogenaemia-a neglected disease. Rheumatology (Oxford). 2017;56(9):1445–51.
2.
Zurück zum Zitat Saadoun D, Elalamy I, Ghillani-Dalbin P, Sene D, Delluc A, Cacoub P. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med. 2009;122(12):1128–35.CrossRefPubMed Saadoun D, Elalamy I, Ghillani-Dalbin P, Sene D, Delluc A, Cacoub P. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med. 2009;122(12):1128–35.CrossRefPubMed
3.
Zurück zum Zitat McKee PA, Kalbfleisch JM, Bird RM. Incidence and significance of cryofibrinogenemia. J Lab Clin Med J Lab Clin Med. 1963;61:203–10. McKee PA, Kalbfleisch JM, Bird RM. Incidence and significance of cryofibrinogenemia. J Lab Clin Med J Lab Clin Med. 1963;61:203–10.
4.
Zurück zum Zitat Blain H, Cacoub P, Musset L, Costedoat-Chalumeau N, Silberstein C, Chosidow O, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120(2):253–60.CrossRefPubMedPubMedCentral Blain H, Cacoub P, Musset L, Costedoat-Chalumeau N, Silberstein C, Chosidow O, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120(2):253–60.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Belizna CC, Tron F, Joly P, Godin M, Hamidou M, Lévesque H. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford). 2008;47(2):205–7.CrossRef Belizna CC, Tron F, Joly P, Godin M, Hamidou M, Lévesque H. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford). 2008;47(2):205–7.CrossRef
6.
Zurück zum Zitat van Geest AJ, et al. Familial primary cryofibrinogenemia. J Eur Acad Dermatol Venereol. 1999;12(1):47–50.CrossRefPubMed van Geest AJ, et al. Familial primary cryofibrinogenemia. J Eur Acad Dermatol Venereol. 1999;12(1):47–50.CrossRefPubMed
7.
Zurück zum Zitat Wulffraat N, et al. Familial presence of primary cryofibrinogenaemia, a report of three cases. Br J Rheumatol. 1996;35(1):102–4.CrossRefPubMed Wulffraat N, et al. Familial presence of primary cryofibrinogenaemia, a report of three cases. Br J Rheumatol. 1996;35(1):102–4.CrossRefPubMed
8.
Zurück zum Zitat Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl). 2007;85(5):531–7.CrossRef Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl). 2007;85(5):531–7.CrossRef
9.
Zurück zum Zitat Rice GI, Rodero MP, Crow YJ. Human disease phenotypes associated with mutations in TREX1. J Clin Immunol. 2015;35(3):235–43.CrossRefPubMed Rice GI, Rodero MP, Crow YJ. Human disease phenotypes associated with mutations in TREX1. J Clin Immunol. 2015;35(3):235–43.CrossRefPubMed
10.
Zurück zum Zitat Sugiura K, Takeichi T, Kono M, Ito Y, Ogawa Y, Muro Y, et al. Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3′-repair exonuclease 1. J Invest Dermatol. 2012;132(12):2855–7.CrossRefPubMed Sugiura K, Takeichi T, Kono M, Ito Y, Ogawa Y, Muro Y, et al. Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3′-repair exonuclease 1. J Invest Dermatol. 2012;132(12):2855–7.CrossRefPubMed
11.
Zurück zum Zitat Tungler V, et al. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol. 2012;167(1):212–4.CrossRefPubMed Tungler V, et al. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol. 2012;167(1):212–4.CrossRefPubMed
12.
Zurück zum Zitat Abe J, Izawa K, Nishikomori R, Awaya T, Kawai T, Yasumi T, et al. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus. Rheumatology (Oxford). 2013;52(2):406–8.CrossRef Abe J, Izawa K, Nishikomori R, Awaya T, Kawai T, Yasumi T, et al. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus. Rheumatology (Oxford). 2013;52(2):406–8.CrossRef
13.
Zurück zum Zitat Gunther C, et al. Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol. 2013;69(4):e179–81.CrossRefPubMed Gunther C, et al. Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol. 2013;69(4):e179–81.CrossRefPubMed
14.
Zurück zum Zitat Yamashiro K, Tanaka R, Li Y, Mikasa M, Hattori N. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus. J Neurol. 2013;260(10):2653–5.CrossRefPubMed Yamashiro K, Tanaka R, Li Y, Mikasa M, Hattori N. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus. J Neurol. 2013;260(10):2653–5.CrossRefPubMed
15.
Zurück zum Zitat Gunther C, et al. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3′ repair exonuclease 1 (TREX1). JAMA Dermatol. 2015;151(4):426–31.CrossRefPubMed Gunther C, et al. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3′ repair exonuclease 1 (TREX1). JAMA Dermatol. 2015;151(4):426–31.CrossRefPubMed
16.
Zurück zum Zitat Kisla Ekinci RM, Balci S, Bisgin A, Altintas DU, Yilmaz M. A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur J Med Genet. 2017;60(12):690–4.CrossRefPubMed Kisla Ekinci RM, Balci S, Bisgin A, Altintas DU, Yilmaz M. A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur J Med Genet. 2017;60(12):690–4.CrossRefPubMed
17.
Zurück zum Zitat Lolin Y, Razis PA, O’Gorman P, Hjelm M, Wierzbicki AS. Transient nephrotic syndrome after anaesthesia resulting from a familial cryofibrinogen precipitating at 35 degrees C. J Med Genet. 1989;26(10):631–6.CrossRefPubMedPubMedCentral Lolin Y, Razis PA, O’Gorman P, Hjelm M, Wierzbicki AS. Transient nephrotic syndrome after anaesthesia resulting from a familial cryofibrinogen precipitating at 35 degrees C. J Med Genet. 1989;26(10):631–6.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Grieves JL, Fye JM, Harvey S, Grayson JM, Hollis T, Perrino FW. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci U S A. 2015;112(16):5117–22.CrossRefPubMedPubMedCentral Grieves JL, Fye JM, Harvey S, Grayson JM, Hollis T, Perrino FW. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci U S A. 2015;112(16):5117–22.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat de Silva U, Choudhury S, Bailey SL, Harvey S, Perrino FW, Hollis T. The crystal structure of TREX1 explains the 3′ nucleotide specificity and reveals a polyproline II helix for protein partnering. J Biol Chem. 2007;282(14):10537–43.CrossRefPubMed de Silva U, Choudhury S, Bailey SL, Harvey S, Perrino FW, Hollis T. The crystal structure of TREX1 explains the 3′ nucleotide specificity and reveals a polyproline II helix for protein partnering. J Biol Chem. 2007;282(14):10537–43.CrossRefPubMed
21.
Zurück zum Zitat Fye JM, Orebaugh CD, Coffin SR, Hollis T, Perrino FW. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J Biol Chem. 2011;286(37):32373–82.CrossRefPubMedPubMedCentral Fye JM, Orebaugh CD, Coffin SR, Hollis T, Perrino FW. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J Biol Chem. 2011;286(37):32373–82.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Aicardi J, Goutieres F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol. 1984;15(1):49–54.CrossRefPubMed Aicardi J, Goutieres F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol. 1984;15(1):49–54.CrossRefPubMed
23.
Zurück zum Zitat Haaxma CA, Crow YJ, van Steensel MAM, Lammens MMY, Rice GI, Verbeek MM, et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutieres syndrome. Am J Med Genet A. 2010;152A(10):2612–7.CrossRefPubMed Haaxma CA, Crow YJ, van Steensel MAM, Lammens MMY, Rice GI, Verbeek MM, et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutieres syndrome. Am J Med Genet A. 2010;152A(10):2612–7.CrossRefPubMed
24.
Zurück zum Zitat Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, et al. Chilblain lupus erythematosus-a review of literature. Clin Rheumatol. 2008;27(10):1341.CrossRefPubMed Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, et al. Chilblain lupus erythematosus-a review of literature. Clin Rheumatol. 2008;27(10):1341.CrossRefPubMed
25.
Zurück zum Zitat Toribara NW, Roberton AM, Ho SB, Kuo WL, Gum E, Hicks JW, et al. Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem. 1993;268(8):5879–85.PubMed Toribara NW, Roberton AM, Ho SB, Kuo WL, Gum E, Hicks JW, et al. Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem. 1993;268(8):5879–85.PubMed
26.
Zurück zum Zitat Kara Eroglu F, et al. STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children. Pediatr Rheumatol Online J. 2015;13(supp 1):O85.CrossRef Kara Eroglu F, et al. STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children. Pediatr Rheumatol Online J. 2015;13(supp 1):O85.CrossRef
28.
Zurück zum Zitat de Vries PS, Chasman DI, Sabater-Lleal M, Chen MH, Huffman JE, Steri M, et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. Hum Mol Genet. 2016;25(2):358–70.CrossRefPubMed de Vries PS, Chasman DI, Sabater-Lleal M, Chen MH, Huffman JE, Steri M, et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. Hum Mol Genet. 2016;25(2):358–70.CrossRefPubMed
29.
Zurück zum Zitat Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol. 2008;17(7):553–68.CrossRefPubMed Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol. 2008;17(7):553–68.CrossRefPubMed
Metadaten
Titel
TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia
verfasst von
C. Paradis
M. Cadieux-Dion
C. Meloche
M. Gravel
J. Paradis
A. Des Roches
G. Leclerc
P. Cossette
P. Begin
Publikationsdatum
26.01.2019
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2019
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-018-0584-x

Weitere Artikel der Ausgabe 1/2019

Journal of Clinical Immunology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.